Scendea’s Post

Speaker Profile >> RWE-Driven MedTech: Achieving Reliability & Relevance with Real-World Data Trevor Carden, Director of Scientific Affairs at Teleflex, joins our upcoming symposium, speaking on "Real-World Data Collection to Fulfill Global Evidence Needs." Trevor will cover strategies for meeting regulatory requirements and achieving corporate objectives such as label expansion, product claims and enhanced market access. Don't miss out on insights that could redefine your approach to compliance and market strategies! #MedTech #RegulatoryAffairs #LabelExpansion 👉 Learn more and register: hubs.ly/Q02Qkh1C0

Are you finally locking down your scheduling for the left coast trifecta of: #JPM25, #2025CERSI Innovations in Reg Science Summit and #BiotechShowcase2025? Me too! The #CatalystHealthcareConsulting team will be in SF sharing strategic insights around FDA, likely new initiatives, and how the new Adminstration will view innovative therapies and digital tools. We’ll also be meeting tech/investment leaders to brainstorm upcoming policy trends we may need to support. So, if you are a client, partner, colleague (or want to be) and have interesting topics to discuss, please reach out so I can set something up.

🌟 Highlights from the ACCORD Conference 🌟 Professor Alexander Dömling recently gave a great talk at the ACCORD conference. He spoke about how using automation and making smaller tools can speed up the making of new medicines. His 30-minute presentation was really interesting and got everyone talking. Big thanks to Alexander Dömling for sharing his knowledge and to the organizers for such a well-run event! #ACCORDConference #DrugDesign #InnovationInMedicine #AlexanderDomling Czech Advanced Technology and Research Institute

Read our new publication on transforming the clinical trials enterprise and enabling the future workforce to better support the evolving needs of drug research and development – one that is resilient, culturally aware, anti-racist, and interdisciplinary. The publication explores the expertise and disciplines needed to diversify and bolster capacity by 2030. Read now: https://ow.ly/WVG650RXobY #DrugForum #ClinicalTrials #Workforce #DiversityinSTEM

Custom Functional Service Provider (FSP) models designed for biotech growth. Discover how Precision for Medicine helps you scale smarter. https://lnkd.in/eSeKaqqa

The process of bringing a new medicine to market is lengthy, expensive and incredibly uncertain. Intellectual property protections help incentivize this investment and research, bringing new, valuable medicines to patients. See how: https://lnkd.in/eH2NeTP5

In this episode of Disruptors x CDL: The Innovation Era, hosts John Stackhouse and Sonia Sennik dive into the rapidly evolving world of life sciences, exploring how Canada can leverage its strengths to lead in global drug discovery and healthcare innovation.

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li. https://ow.ly/lAec50TmOK3 #ClinicalTrials #HealthTech #PharmaInnovation #ClinicalResearch

Discover how technology enhances clinical trials. Advanced tools and analytics improve efficiency and accuracy, driving faster, more reliable research outcomes. Learn more with PolyCRA. #SanAntonioTX #ClinicalResearchTraining #TechInResearch

Why use #digitalintel and #socialmedialistening within the #lifesciences industry? ➡️ To identify evidence gaps ➡️ To highlight unmet medical needs within your patient group/s ➡️ To support regulatory filings for your product/s ➡️ To deliver improved patient outcomes by understanding the voice of the patient ➡️ To discover what support and education HCPs need within your therapy area ➡️ To identify incoming opportunities and threats within the industry To read more about how we've helped our life sciences clients visit www.roarintel.com